Tag: BCS classification

Bioequivalence Waivers: When the FDA Skips In-Vivo Studies

• May 5, 2026
• Kiera Masterson

Discover when the FDA allows bioequivalence waivers, skipping costly human trials for generic drugs. Learn about BCS Class I and III eligibility, dissolution testing requirements, and the financial benefits of biowaivers.